New stent trial aims to improve outcomes for tough heart blockages
Disease control
Not yet recruiting
This study will track 2000 people with complex coronary artery disease who receive the Inspiron EVO drug-eluting stent during a procedure to open blocked heart arteries. The goal is to see how well the stent works and how safe it is in real-world patients with challenging blockag…
Sponsor: Scitech Produtos Medicos SA • Aim: Disease control
Last updated May 20, 2026 11:56 UTC